CULT Food Science Subsidiary Further Foods to Launch Noochies! Sprinkles for Dogs and Cats

Sep 25, 2024

TORONTO, - CULT Food Science Corp. ("CULT" or the "Company") (CSE: CULT) (OTC: CULTF) (FRA: LN00), a disruptive food technology platform pioneering the commercialization of lab grown meat and cellular agriculture to reshape the global food industry, is thrilled to announce that its subsidiary, Further Foods Inc., will be launching its Sprinkles line of toppers to customers in the United States and Canada in October. Pet parents will be able to boost their pets' meals with a unique blend of cultured ingredients that support digestion, nutrient absorption and immunity.

Key Takeaways:

Noochies! Sprinkles toppers will be available to customers in the United States and Canada starting in October.
Launch of 6 new SKUs will bring the total Noochies! product offering to 8 different products.
Further Foods has received positive initial feedback from the FDA regarding its feeding trial design for cell-cultivated chicken in dog food products.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.